BTG Pactual Asset Management US »

Regeneron Pharmaceuticals shares owned by BTG Pactual Asset Management US

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by BTG Pactual Asset Management US from 13F filings

Historical chart of BTG Pactual Asset Management US investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by BTG Pactual Asset Management US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by BTG Pactual Asset Management US

Quarter filed Position value Share count Share price at filing
2026-06-30 $369k 591 623.54

More positions owned by BTG Pactual Asset Management US

Vanguard Index Fds S&p 500 Etf Shs (VOO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard World Mega Grwth Ind (MGK)
JPMorgan Chase & Co. (JPM)
Vanguard World Mega Cap Val Etf (MGV)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Bank of America Corporation (BAC)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Listed Fds Tr Roun Ma Seve Etf Put Option (MAGS)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)

View all positions for BTG Pactual Asset Management US

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
Dodge & Cox
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Franklin Resources
Geode Capital Management
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Capital World Investors
Goldman Sachs Group
Morgan Stanley

View all funds holding Regeneron Pharmaceuticals